Artiva Biotherapeutics ARTV
NASDAQ ARTV
$4.07 +0.01 (+0.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Artiva Biotherapeutics (ARTV) Accounts Payables (2023 - 2026)

Updated

Analysis

Artiva Biotherapeutics (ARTV) Accounts Payables (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 5.79 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 9.32 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 34.43 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.03 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -23.57 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 2.95 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 934.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.07 Bn
10 Artiva Biotherapeutics 200.70 Mn -118.40 Mn - 2.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 2.04 Mn
Jun 30, 2026 1.39 Mn
Mar 31, 2026 2.29 Mn
Dec 31, 2025 355,000.00
Sep 30, 2025 848,000.00
Jun 30, 2025 1.22 Mn
Mar 31, 2025 2.04 Mn
Dec 31, 2024 1.12 Mn
Sep 30, 2024 1.22 Mn
Jun 30, 2024 823,000.00
Dec 31, 2023 614,000.00
Sep 30, 2023 617,000.00
Jun 30, 2023 66,000.00
API Access

Artiva Biotherapeutics Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=ARTV&period=max&api_key=YOUR_API_KEY